Tell L, Romankulov E and Lysenkov S*

Astana Medical University, Kazakhstan

*Corresponding Author: Lysenkov S, Astana Medical University, Kazakhstan.

Received: January 28, 2022; Published: March 01, 2022

The dietary supplement "Bapilact" is recommended for use for the prevention of intestinal microbiocinosis disorders. It is a dietary supplement based on Bapol with enhanced prebiotic properties and an inhibitory effect on the pathogenic microflora of the human intestine.

References

1. Vasilaki AF. “Healthcare”. Chisinau 5 (1988): 47-49.
2. Tel LZ and Lysenkov SP. "Method of obtaining a food product "Bapol"". Preliminary patent of the Republic of Kazakhstan (1996).
3. Katileviciute A., et al. “A Sight to Wheat Bran: High Value-Added Products”. Biomolecules12 (2019): 887.
4. Stevenson L., et al. “Wheat bran: its composition and benefits to health, a European perspective”. International Journal of Food Science and Nutrition8 (2012): 1001-13.
5. McRorie JW Jr., et al. “Laxative effects of wheat bran and psyllium: Resolving enduring misconceptions about fiber in treatment guidelines for chronic idiopathic constipation”. Journal of the American Association of Nurse Practitioners 1 (2020): 15-23.
6. Ferguson LR and Harris PJ. “Protection against cancer by wheat bran: role of dietary fibre and phytochemicals”. European Journal of Cancer Prevention 1 (1999): 17-25.

Citation

Citation: Lysenkov S., et al. “Brief Description of the Dietary Supplement "Bapilact"". Acta Scientific Nutritional Health 6.4 (2022): 01.

Copyright

Copyright: © 2022 Lysenkov S., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.